Population-based study of hypoglycemia in patients with type 1 diabetes mellitus requiring emergency medical services

Endocrine Practice

Volumn 18, Issue 6, 2012, Pages 834-841

  Parsaik, Ajay K ^a   Carter, Rickey E ^a   Myers, Lucas A ^a   Geske, Jennifer R ^a   Smith, Steven A ^a   Levine, James ^a,b   Basu, Ananda ^a   Kudva, Yogish C ^a  

^a MAYO CLINIC ROCHESTER   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; METFORMIN;

ADULT; ARTICLE; CONTROLLED STUDY; EMERGENCY HEALTH SERVICE; FEMALE; HOSPITALIZATION; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MORTALITY; POPULATION; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ADULT; AGED; COHORT STUDIES; DIABETES MELLITUS, TYPE 1; DRUG THERAPY, COMBINATION; EMERGENCY MEDICAL SERVICES; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPOGLYCEMIA; INCIDENCE; INFUSIONS, SUBCUTANEOUS; INJECTIONS; INSULIN; ISLETS OF LANGERHANS TRANSPLANTATION; MALE; METFORMIN; MIDDLE AGED; MINNESOTA; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84871378542     PISSN: 1530891X     EISSN: 19342403     Source Type: Journal    
DOI: 10.4158/EP12094.OR     Document Type: Article

References (27)

1. Kellogg TA, Bantle JP, Leslie DB, et al. Postgastric bypass hyperinsulinemic hypoglycemia syndrome: characterization and response to a modified diet. Surg Obes Relat Dis. 2008; 4: 492-499.
2. Cryer PE. Elimination of hypoglycemia from the lives of people affected by diabetes. Diabetes. 2011; 60: 24-27.
3. Evans JM, Ogston SA, Emslie-Smith A, Morris AD. Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin. Diabetologia. 2006; 49: 930-936.
4. Potter J, Clarke P, Gale EA, Dave SH, Tattersall RB. Insulin-induced hypoglycaemia in an accident and emergency department: the tip of an iceberg? Br Med J (Clin Res Ed). 1982; 285: 1180-1182.
5. Daniels A, White M, Stander I, Crone D. Ambulance visits for severe hypoglycaemia in insulin-treated diabetes. N Z Med J. 1999; 112: 225-228.
6. Ginde AA, Espinola JA, Camargo CA Jr. Trends and disparities in U.S. emergency department visits for hypoglycemia, 1993-2005. Diabetes Care. 2008; 31: 511-513.
7. Thompson CJ, Cummings JF, Chalmers J, Gould C, Newton RW. How have patients reacted to the implications of the DCCT? Diabetes Care. 1996; 19: 876-879.
8. Tamborlane WV, Beck RW, Bode BW, et al (Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group). Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med. 2008; 359: 1464-1476.
9. Bergenstal RM, Tamborlane WV, Ahmann A, et al (STAR 3 Study Group). Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes [published correction appears in N Engl J Med. 2010; 363: 1092]. N Engl J Med. 2010; 363: 311-320.
10. Davis SN, Horton ES, Battelino T, Rubin RR, Schulman KA, Tamborlane WV. STAR 3 randomized controlled trial to compare sensor-augmented insulin pump therapy with multiple daily injections in the treatment of type 1 diabetes: research design, methods, and baseline characteristics of enrolled subjects. Diabetes Technol Ther. 2010; 12: 249-255.
11. US Census Bureau. State and County QuickFacts: Olmsted County, Minnesota. http://quickfacts.census.gov/qfd/states/27/27109.html. Accessed for verification May 27, 2012.
12. Zoungas S, Patel A, Chalmers J, et al (ADVANCE Collaborative Group). Severe hypoglycemia and risks of vascular events and death. N Engl J Med. 2010; 363: 1410-1418.
13. Leese GP, Wang J, Broomhall J, et al (DARTS/MEMO Collaboration). Frequency of severe hypoglycemia requiring emergency treatment in type 1 and type 2 diabetes: a population-based study of health service resource use. Diabetes Care. 2003; 26: 1176-1180.
14. Cryer PE, Axelrod L, Grossman AB, et al (Endocrine Society). Evaluation and management of adult hypoglycemic disorders: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2009; 94: 709-728.
15. Collier JD, Ninkovic M, Compston JE. Guidelines on the management of osteoporosis associated with chronic liver disease. Gut. 2002; 50(suppl 1): i1-i9.
16. Fadem SZ, Rosenthal B. CKD EPI & MDRD GFR Calculator (With SI Units). http://www.kidney.org/professionals/kdoqi/gfr-calculator.cfm. Accessed for verification May 27, 2012.
17. Arlt W. The approach to the adult with newly diagnosed adrenal insufficiency. J Clin Endocrinol Metab. 2009; 94: 1059-1067.
18. Parsaik AK, Murad MH, Sathananthan A, et al. Metabolic and target organ outcomes after total pancreatectomy: Mayo Clinic experience and meta-analysis of the literature. Clin Endocrinol (Oxf). 2010; 73: 723-731.
19. Frier BM, Fisher BM. Hypoglycemia and Diabetes: Clinical and Physiological Aspects. London, UK: Edward Arnold Publications, 1993: 190.
20. Hirsch IB, Bode BW, Garg S, et al (Insulin Aspart CSII/MDI Comparison Study Group). Continuous subcutaneous insulin infusion (CSII) of insulin aspart versus multiple daily injection of insulin aspart/insulin glargine in type 1 diabetic patients previously treated with CSII. Diabetes Care. 2005; 28: 533-538.
21. Jeitler K, Horvath K, Berghold A, et al. Continuous subcutaneous insulin infusion versus multiple daily insulin injections in patients with diabetes mellitus: systematic review and meta-analysis. Diabetologia. 2008; 51: 941-951.
22. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993; 329: 977-986.
23. Fatourechi MM, Kudva YC, Murad MH, Elamin MB, Tabini CC, Montori VM. Clinical review: hypoglycemia with intensive insulin therapy; a systematic review and meta-analyses of randomized trials of continuous subcutaneous insulin infusion versus multiple daily injections. J Clin Endocrinol Metab. 2009; 94: 729-740.
24. Hamman RF. Mortality risk in long-standing type 1 diabetes: hope and concern. Diabetes. 2010; 59: 2997-2998.
25. Dawson SI, Willis J, Florkowski CM, Scott RS. Cause-specific mortality in insulin-treated diabetic patients: a 20-year follow-up. Diabetes Res Clin Pract. 2008; 80: 16-23.
26. Secrest AM, Becker DJ, Kelsey SF, Laporte RE, Orchard TJ. Cause-specific mortality trends in a large population-based cohort with long-standing childhood-onset type 1 diabetes. Diabetes. 2010; 59: 3216-3222.
27. Shen J, Gaglia J. Hypoglycemia following pancreas transplantation. Curr Diab Rep. 2008; 8: 317-323.